QuidelOrtho (QDEL)
Runs hospital lab instruments and point-of-care rapid tests under one roof.
$10.70
vs last close−0.24 (−2.22%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Oct 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 744 | 743 | 711 | 637 | 727 | 708 | 693 | 614 | 700 | 724 | 620 | 631 |
| Cost of revenue | 375 | 361 | 379 | 361 | 375 | 382 | 350 | 339 | 364 | 403 | 356 | 358 |
| Gross profit | 369 | 381 | 332 | 276 | 352 | 326 | 343 | 275 | 336 | 320 | 264 | 273 |
| 343 | 341 | 2,090 | 394 | 337 | 427 | 311 | 456 | 1,040 | 387 | 291 | 295 | |
| Research & development | 62 | 59 | 59 | 56 | 56 | 47 | 53 | 46 | 42 | 46 | 45 | 49 |
| 194 | 188 | 205 | 188 | 186 | 188 | 187 | 178 | 187 | 194 | 199 | 190 | |
| Selling & marketing | 0 | 0 | 0 | 0 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & administrative | 0 | 0 | 0 | 0 | 0 | 181 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other expenses | 88 | 94 | 1,826 | 149 | 95 | 192 | 71 | 232 | 812 | 147 | 47 | 56 |
| Operating income | 26 | 40 | −1,758 | −118 | 15 | −100 | 33 | −181 | −705 | −66 | −27 | −22 |
| −42 | −49 | −41 | −45 | −44 | −41 | −41 | −49 | −52 | −46 | −52 | −59 | |
| Interest income | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 3 | 0 | 3 | 1 | 0 |
| Interest expense | 29 | 46 | 32 | 48 | 50 | 45 | 42 | 46 | 46 | 43 | 51 | 55 |
| Other non-operating income | −5 | 3 | −5 | −2 | −6 | −4 | −1 | 6 | 4 | 3 | 4 | 5 |
| Income before tax | −16 | −9 | −1,799 | −163 | −29 | −141 | −9 | −230 | −757 | −112 | −80 | −81 |
| Income tax expense | −3 | −16 | −93 | −15 | −9 | 38 | 4 | 26 | −24 | 18 | 12 | 12 |
| Net income from continuing operations | −13 | 7 | −1,706 | −148 | −20 | −178 | −13 | −255 | −733 | −131 | −92 | −93 |
| Net income | −13 | 7 | −1,706 | −148 | −20 | −178 | −13 | −255 | −733 | −131 | −92 | −93 |
| EPS, basic | −$0.19 | $0.10 | −$25.50 | −$2.20 | −$0.30 | −$2.28 | −$0.19 | −$3.77 | −$10.78 | −$1.95 | −$1.35 | −$1.36 |
| EPS, diluted | −$0.19 | $0.10 | −$25.50 | −$2.20 | −$0.30 | −$2.28 | −$0.19 | −$3.77 | −$10.78 | −$1.95 | −$1.35 | −$1.36 |
| Weighted average shares, basic | 67 | 67 | 67 | 67 | 67 | 67 | 68 | 68 | 68 | 68 | 68 | 68 |
| Weighted average shares, diluted | 67 | 67 | 67 | 67 | 67 | 67 | 68 | 68 | 68 | 68 | 68 | 68 |
| EBITDA | 144 | 152 | −1,638 | 1 | 134 | 13 | 141 | −76 | −597 | 43 | 81 | −27 |
| Depreciation & amortization | 113 | 115 | 115 | 116 | 113 | 109 | 107 | 110 | 112 | 113 | 113 | 0 |
| EBIT | 31 | 37 | −1,753 | −115 | 21 | −96 | 34 | −187 | −709 | −69 | −32 | −27 |
